Initially 50 or 100 mg/day in 2 equally divided doses, once in the morning & once in the evening. Dose may be adjusted between 50-200 mg/day if necessary. Inj/infusion may be given as an IV bolus or diluted in a compatible soln & administered as a 15-min IV infusion. Hepatic impairment Initially 50 mg/day. Max: 150 mg daily in 2 divided doses.
View Briviact overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food: Tab: Swallow whole w/ liqd. Oral soln: May be diluted in water or juice shortly before administration orally, via nasogastric or gastrostomy tube.
Contraindications
Hypersensitivity to brivaracetam or other pyrrolidone derivatives.
Monitor patients for signs of suicidal ideation & behaviours. Minor or moderate influence on the ability to drive & use machines. Hepatic impairment. Not recommended in end-stage renal disease patients undergoing dialysis. Women of childbearing potential. Pregnancy & lactation. Elderly ≥65 yr. Childn <16 yr. FC tab: Rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption. Oral soln: Rare hereditary problems of fructose intolerance. Contains methyl parahydroxybenzoate (E218). Oral soln & vial: Patients on controlled Na diet.
Sign Out
